Pear Bio specializes in personalizing cancer treatment by using innovative approaches to tailor therapies to individual patients. The company has developed a unique test that cultures patient tumor samples alongside matched immune cells, allowing for the monitoring of dynamic cell behaviors in response to various therapeutic exposures. This process helps identify effective treatment options and serves as both a clinical decision-support tool and a platform for drug discovery. Pear Bio's mission is to address the significant unmet needs in cancer care through cutting-edge technology and a comprehensive biobank. Based in London and Boston, the company operates as a venture capital-backed startup, emphasizing collaboration, integrity, and a commitment to advancing patient-centered solutions in oncology. Job seekers interested in contributing to the future of personalized medicine in an engaging startup environment may find opportunities at Pear Bio aligning with their aspirations.